Clinical Trials

Showing trials with last updates posted in 2013.

NCT00316953 | COMPLETED | PHASE1
48 participants

Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate

Study Type:
INTERVENTIONAL
Last Updated:
2013-02-05
Start Date:
2006-03-31
Completion:
2009-09-30
Conditions
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Blastic Phase Chronic Myelogenous Leukemia
  • Childhood Chronic Myelogenous Leukemia
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Meningeal Chronic Myelogenous Leukemia
  • Recurrent Childhood Acute Lymphoblastic Leukemia
  • Relapsing Chronic Myelogenous Leukemia
  • Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
  • DRUG
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page